3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Precursor Cell Lymphoblastic Leukemia-Lymphoma
3
Leukemia, Myeloid, Acute
2
Waldenstrom Macroglobulinemia
1
Thrombocytopenia
1
Sezary Syndrome
1
Recurrence
1
Reconstructive Surgical Procedure
1
Neutropenia
1
Neuroectodermal Tumors, Primitive, Peripheral
1
Neoplasms
1
Neoplasm, Residual
1
Mycosis Fungoides
1
Multiple Myeloma
1
Motor Activity
1
Lymphopenia
1
Lymphoma, T-Cell, Cutaneous
1
Lymphoma, Non-Hodgkin
1
Lymphoma, Follicular
1
Lymphoma, B-Cell, Marginal Zone
1
Leukemia, Myeloid, Chronic-Phase
1
Leukemia, Myeloid, Accelerated Phase
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Leukemia, Large Granular Lymphocytic
1
Leukemia, Hairy Cell
1
Leukemia
1
Hodgkin Disease
1
Hematologic Neoplasms
1
Dupuytren Contracture
1
Congenital Abnormalities
1
Carcinoma, Renal Cell
1
Interventions
xiapex
1
Transplantation
1
Therapeutics
1
Surveys and Questionnaires
1
Surgical Procedures, Operative
1
Restraint, Physical
1
Radiotherapy
1
High-Energy Shock Waves
1
Extracorporeal Shockwave Therapy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase NA
×
Dupuytren Contracture
×
Transplantation
×
Clear all
NCT05067764
2026-04-23
REMEDY
Elsan
Phase NA
Recruiting
172 enrolled